One hundred patients with newly diagnosed multiple myeloma (MM) were treated with high-dose chemotherapy followed by single or double autologous stem cell transplantation (ASCT). Up-front treatment with a double ASCT tended to prolong progression-free and overall survival.
Figures & Tables
Article Information
Vol. 90 No. 4 (2005): April, 2005 : Letters to the Editor
Published
2005-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Article Usage
Online Views
279
PDF Downloads
85
Statistics from Altmetric.com
No Data
How to Cite
1.
M Putkonen, A Rauhala, M Itala, M Kauppila, TT Pelliniemi, K Remes. Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients. Haematologica 2005;90(4):562-563; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
